Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 by in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Personalized vs. Precision Medicine

Posted on February 3rd, 2017 by in Pharma R&D

Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), Continue reading “Personalized vs. Precision Medicine” »

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

What Does the 2016 US Election Mean For Pharma?

Posted on June 28th, 2016 by in Pharma R&D

With summer, the 2016 U.S. Presidential Election is now truly heating up as we have presumptive nominees from the two major political parties. While we are hearing a lot about issues like national security and immigration from Republican nominee Donald Trump and Democratic nominee Hillary Clinton, those working in the pharmaceutical industry may be wondering how their sector will be affected by the eventual winner. Continue reading “What Does the 2016 US Election Mean For Pharma?” »